Actively Recruiting

Phase Not Applicable
Age: 22Years +
All Genders
ID06561932

A Feasibility Study Implant of the WiSE CRT System With an Intracardiac Pacemaker to Achieve Totally Leadless CRT

Led by EBR Systems, Inc. · Updated on 2026-02-06

40

Participants Needed

4

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the safety and effectiveness of co-implanting the WiSE CRT System with an intracardiac pacemaker to achieve a completely leadless cardiac resynchronization therapy (CRT) for patients with heart failure. This single-arm, prospective, multicenter observational study focuses on delivering biventricular pacing by combining left ventricular pacing from the WiSE CRT System with right ventricular stimulation from a co-implanted device. The study aims to understand how well this leadless approach works and its related risks. Participants will receive the WiSE CRT System implanted to provide left ventricular pacing along with an intracardiac pacemaker for right ventricular pacing, together delivering biventricular stimulation. This therapy is given alongside guideline-directed medical therapy. The study observes participants over time without comparing to a control group. During the study, participants will be monitored for device- and procedure-related complications and for evidence of biventricular capture on electrocardiograms at one month and six months after implantation. Researchers will also assess changes in heart function, including ejection fraction, left ventricular end systolic volume, heart failure symptom class, and walking ability at six months. The study includes follow-up visits to evaluate safety and heart performance, with participation lasting at least six months.

CONDITIONS

Brief Title

A Feasibility Study Implant of the WiSE® CRT System With an Intracardiac Pacemaker to Achieve Totally Leadless CRT

Who Can Participate

Age: 22Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient with a class I or IIa indication for CRT device implantation according to guidelines
  • Male or female aged 22 years or older
  • Ability to provide written consent
  • Meets criteria for either de novo totally leadless CRT implant or upgrade from existing pacemaker with symptomatic heart failure
  • Includes patients with symptomatic atrial fibrillation needing AV node ablation or high degree AV block requiring permanent pacing with LVEF ≤ 50%
Not Eligible

You will not qualify if you...

  • Inability or expected inability to attend follow-up visits
  • Pregnant, lactating, or planning pregnancy during study
  • Inability to comply with study follow-up or requirements
  • History of chronic alcohol or drug abuse with current use
  • Non-ambulatory or unstable NYHA class IV heart failure
  • Life expectancy less than 12 months
  • Any other disease or disorder that may increase risk or affect study participation
  • Enrollment in another clinical trial that could confound results

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Up to 1 day

Participants receive the implant of the WiSE CRT System along with an intracardiac pacemaker to achieve totally leadless cardiac resynchronization therapy.

1 implant procedure visit

Treatment

Duration - 6 months

Participants are treated with the WiSE CRT System combined with guideline-directed medical therapy to provide biventricular pacing.

Visits at 1 month and 6 months post-implant

Trial Site Locations

Total: 4 locations

1

Patients of Sunshine Coast University Hospital

Birtinya, Queensland, Australia, 4575

Not Yet Recruiting

2

Royal Brisbane and Women's Hospital

Herston, Queensland, Australia, 4006

Not Yet Recruiting

3

Patients of Gold Coast University Hospital

Southport, Queensland, Australia, 4215

Not Yet Recruiting

4

Princess Alexandra Hospital

Woolloongabba, Queensland, Australia, 4102

Actively Recruiting

Loading map...

Research Team

C

Christine Phillips

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

Extensive Post-discharge Counselling and Phone-based Follow-...

Heart Failure

Actively Recruiting

1 location

Three-Dimensional Assessment of Right Ventricular Function i...

Heart Failure

Actively Recruiting

1 location

Myocardial Fibrosis in Heart Failure: A Pilot Study Using 68...

Myocardial Fibrosis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here